Drug firm Orchid Pharma's standalone net loss narrowed to Rs 60.97 crore during the quarter ended December 31, 2016.
The company had posted a net loss of Rs 94.02 crore in the year-ago period, Orchid Pharma said in a BSE filing.
Its standalone total income from operations also declined to Rs 179.98 crore during the quarter under review from Rs 205.87 crore a year ago.
Shares of Orchid Pharma today closed 2.47 per cent down at Rs 29.65 ascrip on BSE.
Disclaimer: No Business Standard Journalist was involved in creation of this content
